Title: Clinico Pathological Profile of Male Breast Cancer Treated in a Regional Cancer Centre of Eastern India
Authors: Dr Niharika Panda, Dr P K Das, Dr Siba Sankar Mahapatra, Dr Sagarika Samantaray, Dr Lucy Pattanayak
DOI: https://dx.doi.org/10.18535/jmscr/v5i5.10
Abstract
Male Breast Cancer is known to be an uncommon malignancy. Due to less number of cases available the research in the field is very few. The present study is aimed at finding the incidence, the age profile and the histological types and receptor status of male breast cancer cases treated in a Regional Cancer Centre in eastern India. Twenty seven cases of male breast cancer patients were registered in a regional cancer centre. The age wise incidence was observed. The clinicopathological profile like the histopathological pattern, the Tumour Node Metastasis (TNM) staging and the receptor status were analysed from case records. The median age of presentation in our study was found to be 61years. Out of the 27 cases 14 (51.85%) were found to be in advanced stage i.e stage III followed by 9(33.33%) cases in stage II. Apart from the common invasive duct carcinoma few uncommon variants like papillary, metaplastic, mucinous and invasive lobular were also found. In twelve numbers of cases (44.44%) the receptor status was ER +ve, PR +ve and HER-2 neu –ve followed by ER +ve, PR +ve and HER-2 neu +ve. Though maximum number of cases (45%) were found at age of 61-70 still a good number of cases (26%) are also registered at age of 51-60 and followed by 22% in 41-50 indicating that occurrence of male breast cancer is shifting towards younger age groups. Public awareness, early screening and detection shall be a must to have a better treatment response and quality of life.
Keywords-male breast cancer, clinico pathological profile.
References
1. Yap HY, Tashima CK, Blumenschein GR. Male Breast Cancer, a natural history study. Cancer 1979; 44:748-754.
2. Shah P, Robbani I, Shah O. Clinicopathological study of male breast carcinoma: a 24 years of experience. Ann Saudi Med, 2009; 29(4): 288-293.
3. Rai B, Ghoshal S, Sharma SC. Breast Cancer in males: a pgimer experience. J Cancer Res Ther. 2005;1(1):31-33.
4. Sundriyal D, Kotwal S, Dawar R. Male Breast Cancer In India: Series from a Cancer Research Centre. Indian J Surg Oncol 2015;6(4):384-386.
5. Mitra D, Manna A, et al. A clinic pathol-ogical study and its prognostic inplication in male breast carcinoma. JIMA, 2007; 105: 681-683.
6. Keith S, Heller MD et al. Male Breast Cancer, a clinicopathologic study of 97 cases. Ann Surg 1978; 188:1;60-65.
7. Donegan WL, Redlich PN, et al. Carcinoma of the breast in males: a multi-institutional survey. Cancer, 1998; 83: 2139-2149.
8. Joli R Weiss, Kirsten B et al. Epidemiology of Male Breast Cancer. Cancer Epidem-iology Biomarkers & Prev.2005;14(1):20-26.
9. Rouji Zhou, Lin Yu et al. Male breast carcinoma: a clinicopathological and immu-nohistochemical characterization study. Int J Clin Exp Pathol. 2014; 7(10): 6852–6861.
10. Robert Karnegoor, Anoek JH Verschuur-Maes et al. Molecular sub-typing of Male Breast Cancer by immune-histochemistry. Modern Pathology. 2012, 25:398-404.